{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:57:35Z","timestamp":1788908255399,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Bacterial urinary tract infections (UTIs) are prevalent in dogs and necessitate antibiotic intervention. However, the emergence of multidrug-resistant (MDR) bacteria poses significant challenges to antibiotic therapy. Although fosfomycin has been demonstrated to achieve and maintain high concentrations in urine, suggesting its potential for treating UTIs in dogs, its efficacy and the resistance profiles of urinary pathogens from canine UTIs remain elusive. Therefore, this study was conducted to investigate the antibiotic susceptibility of bacterial pathogens isolated from companion dogs with UTIs, with a particular focus on their susceptibility and resistance to fosfomycin. A total of 70 isolates from urine samples were analyzed, of which <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u200918), <jats:italic>Proteus mirabilis<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u20099), <jats:italic>Klebsiella pneumoniae<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u20095), and <jats:italic>Staphylococcus pseudintermedius<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u20095) were predominant. Resistance to erythromycin was most prevalent (94.59%), followed by clindamycin (91.89%) and ampicillin (78.37%), whereas the lowest resistance rate was observed for amikacin (5.40%). Resistance to fosfomycin was observed in 15 out of the 37 predominant isolates (40.54%), including all <jats:italic>K. pneumoniae<\/jats:italic> isolates (100%). All isolates, except 4 <jats:italic>E. coli<\/jats:italic> strains, were categorized as MDR (33 out of 37; 89.18%). The resistance rates for amoxicillin\/clavulanic acid and trimethoprim-sulfamethoxazole, which are common first-line antibiotics for canine UTIs, were 48.64 and 56.75%, respectively. Whole-genome sequencing of <jats:italic>K. pneumoniae<\/jats:italic> isolates, which exhibited high resistance to fosfomycin, revealed multiple antibiotic resistance genes, with chromosomal <jats:italic>fosA<\/jats:italic> present in all isolates. Among the 27 dogs with recurrent infection included in this study, 2 were administered fosfomycin, resulting in clinical remission, as evidenced by negative urine culture tests. Overall, this study is the first to demonstrate the importance of assessing fosfomycin resistance profile for optimal treatment of canine UTIs, particularly in cases involving MDR strains.<\/jats:p>","DOI":"10.3389\/fvets.2024.1455021","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:49:54Z","timestamp":1731498594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotic efficacy and resistance patterns of urinary tract infection-causing bacteria in dogs and resistome of multidrug-resistant Klebsiella pneumoniae via whole genome sequencing in South Korea"],"prefix":"10.3389","volume":"11","author":[{"given":"Da-Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Hyeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/J.CVSM.2018.11.005","article-title":"Urinary tract infection","volume":"49","author":"Byron","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cvsm.2022.01.002","article-title":"Urinary tract infections treatment\/comparative therapeutics","volume":"52","author":"Olin","year":"2022","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tvjl.2019.02.008","article-title":"International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats","volume":"247","author":"Weese","year":"2019","journal-title":"Vet J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","article-title":"An update on the management of urinary tract infections in the era of antimicrobial resistance","volume":"129","author":"Bader","year":"2017","journal-title":"Postgrad Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"DC06\u20139","DOI":"10.7860\/JCDR\/2015\/15227.6951","article-title":"Fosfomycin: an alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance","volume":"9","author":"Sabharwal","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1093\/jac\/dkaa294","article-title":"Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent escherichia coli urinary tract infection","volume":"75","author":"Kuiper","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","article-title":"Fosfomycin Tromethamine","volume":"53","author":"Patel","year":"1997","journal-title":"Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2082693","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: a first-line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijantimicag.2018.09.013","article-title":"Resistance to fosfomycin: mechanisms, frequency and clinical consequences","volume":"53","author":"Falagas","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jgid.jgid_72_17","article-title":"Nitrofurantoin and fosfomycin for extended spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae","volume":"10","author":"Tulara","year":"2018","journal-title":"J Glob Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/antibiotics9050230","article-title":"Urinary pharmacokinetic and pharmacodynamic profiles of fosfomycin against extended-spectrum \u03b2-lactamase-producing escherichia coli with canine ex vivo modeling: a pilot study","volume":"9","author":"Harada","year":"2020","journal-title":"Antibiotics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/vetsci10060391","article-title":"Plasma and urine pharmacokinetics of oral fosfomycin tromethamine in dogs","volume":"10","author":"Jariyapamornkoon","year":"2023","journal-title":"Vet Sci"},{"key":"ref14","volume-title":"Performance standards for antimicrobial susceptibility testing","year":"2021"},{"key":"ref15","year":""},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e01306","DOI":"10.1128\/JCM.01306-20","article-title":"Susceptibility of clinical isolates of Escherichia coli to fosfomycin as measured by four in vitro testing methods","volume":"58","author":"Karlowsky","year":"2020","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/jac\/dkac275","article-title":"In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study","volume":"77","author":"Karlowsky","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/antibiotics10111322","article-title":"Genomic features of Salmonella enterica subspecies houtenae serotype 45:g,z51: isolated from multiple abdominal abscesses of an African fat-tailed gecko, United States, 2020","volume":"10","author":"Hyeon","year":"2021","journal-title":"Antibiotics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/iju.IJU_285_16","article-title":"Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens","volume":"33","author":"Banerjee","year":"2017","journal-title":"Indian J Urol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871526515666150916141907","article-title":"Fosfomycin use in multi drug resistant uropathogenic Escherichia coli","volume":"15","author":"Mittal","year":"2015","journal-title":"Infect Disord Drug Targets"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s11255-017-1627-6","article-title":"Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully","volume":"49","author":"Patwardhan","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4103\/ijccm.IJCCM_67_18","article-title":"In vitro activity of fosfomycin against multidrug-resistant urinary and nonurinary gram-negative isolates","volume":"22","author":"Behera","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/jlp.jlp_27_19","article-title":"Evaluation of in vitro susceptibility of fosfomycin among Enterobacteriaceae isolates from urine cultures: a study from Puducherry","volume":"11","author":"Sreenivasan","year":"2019","journal-title":"J Lab Physicians"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1099\/jmm.0.000874","article-title":"Fosfomycin: mechanisms and the increasing prevalence of resistance","volume":"68","author":"Aghamali","year":"2019","journal-title":"J Med Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.21203\/RS.3.RS-414884\/V1","article-title":"Comparison of in-vitro susceptibility of fosfomycin against drug resistant uropathogens by various susceptibility testing methods","volume":"1","author":"Bir","year":"2022","journal-title":"Res Sq"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.18502\/ijm.v14i5.10956","article-title":"Genomic analysis of fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens","volume":"14","author":"Bir","year":"2022","journal-title":"Iran J Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.rvsc.2014.02.004","article-title":"Fosfomycin susceptibility of canine methicillin-resistant Staphylococcus pseudintermedius isolates","volume":"96","author":"DiCicco","year":"2014","journal-title":"Res Vet Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-018-0426-x","article-title":"Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia","volume":"8","author":"Juan","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11255-015-1018-9","article-title":"Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin","volume":"47","author":"Cho","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"106226","DOI":"10.1016\/j.ijantimicag.2020.106226","article-title":"Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China","volume":"57","author":"Huang","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e00749-17","DOI":"10.1128\/mBio.00749-17","article-title":"Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene","volume":"8","author":"Ito","year":"2017","journal-title":"MBio"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"816806","DOI":"10.3389\/fmicb.2022.816806","article-title":"Transporter genes and fosA associated with fosfomycin resistance in carbapenem-resistant klebsiella pneumoniae","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1455021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:49:57Z","timestamp":1731498597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1455021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":34,"alternative-id":["10.3389\/fvets.2024.1455021"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2024.1455021","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"article-number":"1455021"}}